Promoter creates pledge of 8,50,000 equity shares, 0.47% of total share capital
Promoter V.C. Nannapaneni has created a pledge of 8,50,000 equity shares of Natco Pharma, each of face value Rs.2/-.
By ScoutQuest · · 2 min read
- Shares Pledged
- 8,50,000 equity shares, 0.47% of total share capital
- Pledge Created Date
- 09-10-2026; disclosed to the exchanges on 12-10-2026
- Promoter's Total Holding
- 2,80,45,905 shares, or 15.66%
V.C. Nannapaneni, promoter of the company, has disclosed the creation of a pledge over 8,50,000 equity shares of face value Rs.2/- each, in favour of Bajaj Financial Securities Limited. The disclosure was made to BSE Limited and the National Stock Exchange of India Limited under Regulation 31(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The numbers in the disclosure
- Shares pledged: 8,50,000
- Share of total share capital: 0.47%
- Type of encumbrance: Pledge
- Entity in whose favour the shares are encumbered: Bajaj Financial Securities Limited
- Date of creation of the pledge: 09-10-2026
- Promoter's holding in the company: 2,80,45,905 shares, equal to 15.66% of total share capital
- Shares of the promoter already encumbered before this event: Nil
- Shares encumbered after the event: 8,50,000, equal to 0.47% of total share capital
What a pledge means
- A pledge is a form of encumbrance, not a sale. The promoter continues to hold the shares; the pledge marks them as security in favour of the lender named in the disclosure.
- Before this event the promoter's shares carried no encumbrance; the update shows the encumbered quantity moving from Nil to 8,50,000 shares, which is 0.47% of total share capital.
- Pledged shares come into focus if the borrower defaults, since the lender can then invoke the pledge. The disclosure itself does not change who owns the shares or the promoter's 15.66% holding.
How such a disclosure is generally viewed
- Promoter pledges are tracked because they show a promoter using personal shareholding to raise funds, so the size of the pledge relative to the total holding is the number investors usually weigh.
- Here the pledged quantity is 8,50,000 shares, or 0.47% of total share capital, while the promoter's total holding is 2,80,45,905 shares, or 15.66% of total share capital.
Also from Natco Pharma
Allotment of ~1.71 crore equity shares at ₹750 each under rights issue
23 Oct 2026
Rights Issue period closes today; issue of up to Rs.12,794 millions approved at Rs.750 per share
22 Oct 2026
Carboplatin Injection, generic of Paraplatin, launched in the U.S. market
19 Oct 2026
More numbers
- Equity shares pledged by the promoter8,50,000
- Face value per equity shareRs.2/-
- Promoter's holding in the company (number of shares)2,80,45,905
- Promoter's holding as % of total share capital15.66%
- Pledged shares as % of total share capital0.47%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.